The realized savings represent only a portion of the total opportunity: Noom Med members who combine Nooms behavioral support with GLP-1 therapy lose 39% more weight on average than those on medication alone 1
Lyophilized retatrutide stored properly can remain stable for 12-24 months
MHRA and EMA recognise cholelithiasis and cholecystitis as adverse reactions to GLP-1 therapy requiring ongoing monitoring
PlexusDx explains the clinical reasoning behind weekly dosing rules and offers safe alternatives to avoid confusion
We have completed commercial quantity production of Retatrutide
Across SELECT, STEPlike trials, pediatric obesity studies, and ESSENCE, Wegovy demonstrates robust, durable weight loss, clinically meaningful CV risk reduction, and promising liver histologic responses, albeit with an established GIdominant tolerability profile and specific but manageable safety concerns